Can we decrease recurrence of OSSN using Mitomycin C

Authors

  • Mohammed Ather Professor of Ophthalmology, Gandhi Medical College/ In charge department of Oculoplasty SD eye hospital, Hyderabad, Telangana state, India
  • Dr Nasreen Osmania Medical College, Hyderabad, Telangana State, India
  • T Kavitha Devi Eye Hospital, Regional institute of Ophthalmology, Hyderabad. Telangana State, India
  • Kesava Rao Assistant professor of Ophthalmology, Gandhi Medical College, Musheerabad, Telangana State, India
  • Sara Sultana Junior resident of Ophthalmology, Sarojini Devi Eye Hospital, Hyderabad, Telangana State, India
  • Sharf Amena Junior resident of Pathology, Osmania Medical College, Hyderabad, Telangana state, India

Abstract

Aim: To study the effect of topical Mitomycin C on recurrence of OSSN after surgical excision.

Materials and methods: This is a Randomized prospective interventional study conducted at Sarojini Devi Eye Hospital /Regional institute of Ophthalmology, Hyderabad. 54 clinically diagnosed cases of OSSN attending department of Oculoplasty between October 2012 to September 2014 were included in the study. 36 were males and 18 were females.Cases already treated were excluded from the study. These cases were randomly divided into two groups of 18 males and 9 females.Both the groups were treated by surgical excision of OSSN with 3mm margin of normal conjunctiva and cryo applied to the bare area by freeze thaw freeze technique. Group A was followed up every month for recurrence. Group B were given topical Mitomycin C 0.04% drops 4 times daily for 4days in a week with 3 days off. This constituteone cycle. Patients were kept for 4 cycles on this therapy. This group is also followed up every month for recurrence upto 2 years.

Results: In group A 4 cases (14.8%) developed recurrence of tumor within one year. In group B there was no recurrence.

Conclusion: Mitomycin C as adjuvant therapy after surgical excision of OSSN is effective in preventing recurrence.

Key words: OSSN (Ocular surface squamous neoplasia), MMC (Mitomycin C), HIV (Human immuno-deficiency virus),HPV (Human papilloma virus).

 

DOI

https://doi.org/10.22270/jddt.v5i1.1027

Author Biographies

Mohammed Ather, Professor of Ophthalmology, Gandhi Medical College/ In charge department of Oculoplasty SD eye hospital, Hyderabad, Telangana state, India

Professor of Ophthalmology, Gandhi Medical College/ In charge department of Oculoplasty SD eye hospital, Hyderabad, Telangana state, India

Dr Nasreen, Osmania Medical College, Hyderabad, Telangana State, India

Osmania Medical College, Hyderabad, Telangana State, India

T Kavitha, Devi Eye Hospital, Regional institute of Ophthalmology, Hyderabad. Telangana State, India

Devi Eye Hospital, Regional institute of Ophthalmology, Hyderabad. Telangana State, India

Kesava Rao, Assistant professor of Ophthalmology, Gandhi Medical College, Musheerabad, Telangana State, India

Assistant professor of Ophthalmology, Gandhi Medical College, Musheerabad,  Telangana State, India

Sara Sultana, Junior resident of Ophthalmology, Sarojini Devi Eye Hospital, Hyderabad, Telangana State, India

Junior resident of Ophthalmology, Sarojini Devi Eye Hospital, Hyderabad, Telangana State, India

Sharf Amena, Junior resident of Pathology, Osmania Medical College, Hyderabad, Telangana state, India

Junior resident of Pathology, Osmania Medical College, Hyderabad, Telangana state, India

References

Lee&Hirst Retrospective of OSSN Aus NZJ of Ophthalmology 1997;25:269

Winward et al conjunctival squamous cell carcinoma in HIV case AMJ of Ophthalmology 1989;107:554

Goodman& Gilman ,Pharmacological basis of disease, 11th edition 2005

Shields et al june 1997; Arch. Of ophthalmology,vol. 115 (6) page 805-815

Divine RD et al Cryo therapy for Conjunctival intraepithelial neoplasia, Arch.of Ophthalmology 1983,101;782

Peksayer et al Cryo therapy for OSSN Eye;2003;17,228

H C Russell et al ,Topical MMC in management of OSSN, BJO,2010,94(10):1316-21

A Gupta et al, Management of OSSN with MMC, BJO;2010;94(5):555-558

C Chen et al , MMC as an adjunct in the treatment of OSSN after surgical excision,BJO,Jan, 2004;88(1):17-18

Published

2015-01-13
Statistics
Abstract Display: 490
PDF Downloads: 719

How to Cite

1.
Ather M, Nasreen D, Kavitha T, Rao K, Sultana S, Amena S. Can we decrease recurrence of OSSN using Mitomycin C. J. Drug Delivery Ther. [Internet]. 2015 Jan. 13 [cited 2026 Jan. 17];5(1):92-3. Available from: https://www.jddtonline.info/index.php/jddt/article/view/1027

How to Cite

1.
Ather M, Nasreen D, Kavitha T, Rao K, Sultana S, Amena S. Can we decrease recurrence of OSSN using Mitomycin C. J. Drug Delivery Ther. [Internet]. 2015 Jan. 13 [cited 2026 Jan. 17];5(1):92-3. Available from: https://www.jddtonline.info/index.php/jddt/article/view/1027